Y-mAbs Therapeutics Inc (YMAB)
17.15
-0.10
(-0.58%)
USD |
NASDAQ |
May 03, 16:00
17.11
-0.04
(-0.23%)
After-Hours: 20:00
Y-mAbs Therapeutics Cash from Operations (Quarterly): -8.036M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -8.036M |
September 30, 2023 | -1.338M |
June 30, 2023 | -4.734M |
March 31, 2023 | -13.12M |
December 31, 2022 | -8.661M |
September 30, 2022 | -19.24M |
June 30, 2022 | -23.10M |
March 31, 2022 | -24.92M |
December 31, 2021 | -33.86M |
September 30, 2021 | -18.08M |
June 30, 2021 | -18.76M |
March 31, 2021 | -31.86M |
Date | Value |
---|---|
December 31, 2020 | -17.70M |
September 30, 2020 | -24.14M |
June 30, 2020 | -27.64M |
March 31, 2020 | -21.76M |
December 31, 2019 | -24.58M |
September 30, 2019 | -21.40M |
June 30, 2019 | -14.04M |
March 31, 2019 | -13.48M |
December 31, 2018 | -13.58M |
September 30, 2018 | -9.188M |
June 30, 2018 | -11.86M |
March 31, 2018 | -6.608M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.86M
Minimum
Dec 2021
-1.338M
Maximum
Sep 2023
-18.79M
Average
-19.24M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
The Cooper Companies Inc | 122.70M |
Puma Biotechnology Inc | 10.46M |
Humacyte Inc | -19.05M |
Moderna Inc | -989.00M |
NovaBay Pharmaceuticals Inc | -0.314M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 0.10M |
Free Cash Flow | -27.23M |
Free Cash Flow Per Share (Quarterly) | -0.1842 |
Free Cash Flow to Equity (Quarterly) | -8.036M |
Free Cash Flow to Firm (Quarterly) | -8.036M |
Free Cash Flow Yield | -3.64% |